With industry waiting on the FDA to issue regs for CBD products, the agency instead released a statement explaining why it has not yet done so—including fears that the trendy cannabinoid may cause liver damage. But advocates charge that the claim is based on faulty research.
Recent comments
1 week 6 days ago
6 weeks 8 hours ago
7 weeks 19 hours ago
7 weeks 22 hours ago
28 weeks 1 day ago
32 weeks 2 days ago
33 weeks 6 days ago
34 weeks 8 hours ago
46 weeks 2 days ago
52 weeks 12 hours ago